(Q44158160)

30 November 2017

title

Diagnostic relevance of plasma DNA and DNA integrity for breast cancer (English)

1 reference

30 November 2017

Oliver J Stötzer

1

1 reference

30 November 2017

Julia Lehner

2

1 reference

30 November 2017

Debora Fersching-Gierlich

3

1 reference

30 November 2017

Dorothea Nagel

4

1 reference

30 November 2017

Stefan Holdenrieder

5

1 reference

30 November 2017

publication date

10 September 2013

1 reference

30 November 2017

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

1183-1191

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1158-4

30 November 2017

exact match

0 references

cites work

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Elevated nucleosome levels in systemic inflammation and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Nucleosomal DNA fragments in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Overview of cell death signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Densities, length proportions, and other distributional features of repetitive sequences in the human genome estimated from 430 megabases of genomic sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Plasma cell-free DNA as an indicator of severity of injury in burn patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1158-4

Clinical use of circulating nucleosomes

21 January 2018

1 reference

12 December 2020

Increased plasma DNA integrity in cancer patients.

1 reference

12 December 2020

Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls

1 reference

12 December 2020

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

1 reference

12 December 2020

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival

1 reference

12 December 2020

The role of cell-free DNA size distribution in the management of prostate cancer

1 reference

12 December 2020

Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients

1 reference

12 December 2020

Use of real-time quantitative PCR to compare DNA isolation methods

1 reference

12 December 2020

DNA integrity in plasma and serum of patients with malignant and benign diseases

1 reference

12 December 2020

10.1007/S13277-013-1158-4

Identifiers

DOI

1 reference

30 November 2017

1 reference